Academic Resource Center — Established 2004

The Scientific Study of Antibiotics: Pharmacology & Antimicrobial Stewardship

This Institute provides peer-reviewed, evidence-based academic monographs on the pharmacology, mechanisms of action, and clinical microbiology of systemic antibiotics. All content is produced for educational and research purposes and does not constitute medical advice.

Browse Monographs Read: OTC Antibiotic Risks

Our Academic Mission

The Institute for Antimicrobial Research and Pharmacology (IARP) operates under the academic mandate to advance the rigorous, unbiased scientific understanding of antimicrobial agents. Our Department of Clinical Microbiology & Pharmacology produces in-depth monographs on antibiotic classes currently approved by the United States Food and Drug Administration (FDA), examining each agent through the lens of modern pharmacodynamics and molecular microbiology.

In an era of accelerating antimicrobial resistance (AMR), the Institute's mission extends beyond pharmacokinetic description. We critically analyze the public health implications of antibiotic use patterns, resistance emergence mechanisms, and the imperative of evidence-based antimicrobial stewardship programs (ASPs) in both hospital and community settings across the United States.

Research Focus Areas

  • Antibiotic Mechanisms of Action
  • Pharmacokinetics & Pharmacodynamics
  • Antimicrobial Resistance (AMR)
  • Antimicrobial Stewardship Programs
  • Microbiome & Dysbiosis Research
  • FDA Regulatory Pharmacology

Antibiotic Pharmacology Monographs

Select an antibiotic agent below to access its comprehensive academic monograph, including mechanism of action, pharmacokinetics, spectrum of activity, and resistance considerations.

Tetracycline Class

Doxycycline

Generic Name:
Doxycycline Hyclate / Monohydrate
Drug Class:
Tetracycline Antibiotic
Action:
Bacteriostatic; 30S Ribosomal Inhibition
Half-life:
18–22 hours
Read Monograph

Beta-Lactam Class

Amoxil (Amoxicillin)

Generic Name:
Amoxicillin Trihydrate
Drug Class:
Aminopenicillin (Beta-Lactam)
Action:
Bactericidal; Cell Wall Synthesis Inhibitor
Half-life:
1.0–1.5 hours
Read Monograph

Macrolide Class

Zithromax (Azithromycin)

Generic Name:
Azithromycin Dihydrate
Drug Class:
Azalide Macrolide
Action:
Bacteriostatic; 50S Ribosomal Inhibition
Half-life:
~68 hours (tissue)
Read Monograph

Sulfonamide / DHFR Inhibitor

Bactrim (SMX/TMP)

Generic Name:
Sulfamethoxazole / Trimethoprim
Drug Class:
Sulfonamide Combination
Action:
Bactericidal; Folic Acid Pathway Inhibition
Half-life:
SMX: 10h / TMP: 8–11h
Read Monograph

Fluoroquinolone Class

Cipro (Ciprofloxacin)

Generic Name:
Ciprofloxacin Hydrochloride
Drug Class:
Fluoroquinolone (2nd Gen.)
Action:
Bactericidal; DNA Gyrase / Topo IV Inhibitor
Half-life:
3.5–5 hours
Read Monograph

Featured Scholarly Article

OTC Antibiotics & AMR

A peer-reviewed analysis of FDA regulations distinguishing topical OTC antibiotics from systemic prescription agents, and the public health consequences of unregulated systemic antibiotic access.

Read Article

The Global AMR Crisis: An Urgent Academic Priority

The World Health Organization (WHO) and the United States Centers for Disease Control and Prevention (CDC) classify antimicrobial resistance (AMR) as one of the gravest threats to global public health. In the United States alone, the CDC estimates that more than 2.8 million antibiotic-resistant infections occur annually, resulting in over 35,000 deaths. The Institute's research is directly aligned with understanding and communicating the pharmacological and epidemiological underpinnings of this crisis.

Departmental Research Pillars

Pharmacological Analysis

Rigorous examination of pharmacokinetics (PK), pharmacodynamics (PD), and the molecular mechanisms by which antibiotic agents achieve bacteriostatic or bactericidal effects.

Resistance Mechanisms

Comprehensive study of intrinsic and acquired AMR mechanisms including enzymatic inactivation (beta-lactamases), efflux pump upregulation, target modification, and horizontal gene transfer.

Public Health & Stewardship

Analysis of antimicrobial stewardship programs (ASPs), FDA regulatory frameworks, and the epidemiology of antibiotic misuse in the United States healthcare system.